Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting CD123 in BPDCN: an emerging field.
DiPippo AJ, Wilson NR, Pemmaraju N. DiPippo AJ, et al. Among authors: wilson nr. Expert Rev Hematol. 2021 Nov;14(11):993-1004. doi: 10.1080/17474086.2021.1988848. Epub 2021 Oct 29. Expert Rev Hematol. 2021. PMID: 34607517 Review.
Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm.
Pemmaraju N, Wilson NR, Khoury JD, Jain N, Daver N, Pierce S, Jabbour E, Kadia T, DiNardo C, Garcia-Manero G, Qazilbash M, Konopleva M, Kantarjian H. Pemmaraju N, et al. Among authors: wilson nr. Blood. 2021 Oct 14;138(15):1373-1377. doi: 10.1182/blood.2021011817. Blood. 2021. PMID: 34098573 Free article. No abstract available.
How to Treat Adult Acute Myeloid Leukemia: An Evolving Paradigm.
Wilson NR, Pemmaraju N. Wilson NR, et al. JACC CardioOncol. 2021 Dec 21;3(5):747-751. doi: 10.1016/j.jaccao.2021.09.013. eCollection 2021 Dec. JACC CardioOncol. 2021. PMID: 34988486 Free PMC article. Review. No abstract available.
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD.
Pemmaraju N, Wilson NR, Garcia-Manero G, Sasaki K, Khoury JD, Jain N, Borthakur G, Ravandi F, Daver N, Kadia T, DiNardo C, Jabbour E, Pierce S, Qazilbash M, Konopleva M, Kantarjian H. Pemmaraju N, et al. Among authors: wilson nr. Blood Adv. 2022 May 24;6(10):3027-3035. doi: 10.1182/bloodadvances.2021006645. Blood Adv. 2022. PMID: 35061885 Free PMC article.
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine.
Kim K, Bazinet A, Loghavi S, Konopleva M, Bhalla K, Daver N, Khoury JD, Kadia T, Wilson NR, Curry JL, Heberton M, Miller D, Pierce S, Borthakur G, Pemmaraju N. Kim K, et al. Among authors: wilson nr. Leuk Res. 2022 Aug;119:106884. doi: 10.1016/j.leukres.2022.106884. Epub 2022 May 31. Leuk Res. 2022. PMID: 35691130 No abstract available.
121 results